pm briefings from 9 feb 2016 innovation network event

CDE enduring competition

Enduring competition

Enduring challenges

Protection

Situational awareness

Power and energy

Communication

Lethality

Mobility

Human performance

Lower cost of ownership

Enduring challenge links

How can you get involved?

Centre for Defence Enterprise

Advanced Design and Manufacturing

Wing Commander Jim Pennycook

Centre for Defence Enterprise 030 67704236 030 67704237

cde@dstl.gov.uk www.gov.uk/dstl/cde

Medical sciences part of human performance CDE enduring competition

10 February 2016

Human performance: enduring competition

10 February 2016

Context

• the human component is central to delivering military capability

• provision of sufficient, capable and appropriately trained personnel is critical to operational success

• need to sustain capability by protection, treatment and rehabilitation

• high quality support, care and treatment at all points along the continuum of care

10 February 2016 © Dstl 2014

Themes Systems interface Survivability Sustainment Training and education Medical sciences Physical and mental health

UK OFFICIAL

Defence Human and Medical Sciences will be intrinsic to Future Force Capability. Whole Force supported through Whole Service

Life Care will be the foundation of next generation defence personnel.

The Future Force will achieve a symbiotic relationship with technology, engendering enhanced information management and

exploitation, shaping and influencing the defence and security landscape.

10 February 2016

People matter

UK OFFICIAL

Humans in systems • human optimisation through

augmentation • enhanced integrated systems • adaptive technologies • operation of complex socio-

technical systems

10 February 2016

UK OFFICIAL

Defence personnel • supply • capability • motivation • workforce management • organisational design

10 February 2016

UK OFFICIAL

Training and education • evaluation of alternative training

methods and approaches • technology assessments applied to

the military environment • development of training standards

and guidance • demonstration of training tools for

specific environments

10 February 2016

Medical Sciences research

programme

Providing research which contributes to an improvement in

physical, psychological and social health, in order to maintain

operational effectiveness and minimise mortality, morbidity

and residual disability

10 February 2016

CSA Medical Science programme

• medical science: £3 million • medical operational analysis:

£450,000 • support for National Institute for

Health Research Surgical Reconstruction and Microbiology Research Centre(NIHR SRMRC): £1 million

10 February 2016

Medical Sciences research programme to address Defence Medical Services’ research outcomes

10 February 2016

Increased survival

Reduced recovery

Reduced medical

discharge

Improved medical training

and equipment

Improved force

effectiveness

Improved functional recovery

Research areas with associated priorities

Combat casualty care Whole life service care

Medical Systems & logistics

Simulation for training &

education

Health surveillance

& informatics

Medical OA

Rehabilitation

Regenerative medicine

Environmental & occupational

injuries

Mental health

Resuscitation Haemorrhage control

Pain management

Austere environments Extended evacuation times

Supply of medical

capability

Big data

Freedom from fridges & freezers

10 February 2016

Medical Sciences

• human performance and protection • systems for medics and first responders • simulated environments in defence medical

training • rehabilitation and regenerative medicine

within defence • fit to deploy • operational health and protection • information and analysis

UK OFFICIAL

Exploitation

10 February 2016

Follow-on activities • stakeholder demonstration

Research integration • medical sciences programme

Procurement • refine, trial or purchase

Policy • refinement and implementation • development of doctrine

Chemical, Biological and Radiological Science and Technology Programme

UNCLASSIFIED

Overview

Context Strategic view Programme vision and breadth of activities What do we need to address?

UNCLASSIFIED 10 February 2016

UNCLASSIFIED

National Security Strategy and

Strategic Defence and Security

Review 2015

10 February 2016

UNCLASSIFIED

The next 5 years

10 February 2016

UNCLASSIFIED

The longer term The following aspects of the Tier 1 and 2 risks may become even more likely and/or have a greater impact over the longer term: • antimicrobial resistance • cyber related threats • chemical and biological attacks against the UK or its forces • pressure on allies or undermining of our military and economic

alliances and institutions • emerging infectious diseases • serious and organised crime, eg human trafficking • proliferation: acquisition of nuclear, chemical and biological

weapons (CBW), and advanced conventional weapons by state and non-state actors

10 February 2016

The CBW spectrum illustrates the range of materials that could be used as CBW agents

Toxicindustrialchemicals

(TICS)

Major CWagents

EmergingCW agents

Midspectrum

agents

BW agents

Phosgene

chlorine

ammonia

vesicants

nerve agents

psycho-chemicals

developmentsfrom

pharmaceutical& pesticideresearch(Moscowtheatre)

toxins

bioregulators

bacteria

rickettsia

viruses

increasing potency (up to~1012)

synthetic chemicals

self-replicating

agents of biological origin

UNCLASSIFIED

Programme vision

Through the contribution of science and technology:

• Chemical, Biological and Radiological

(CBR) weapons/materials will have no strategic or tactical effect

• perpetrators will be identified • restraint is rewarded and acceptable

norms are reinforced

10 February 2016 10 February 2016

UNCLASSIFIED

Breadth of activities

Proof of concept

Support to operations

Innovation

Supporting policy

Technology transfer

Test and evaluation

10 February 2016

How do we know if there's been a release of a biological agent, distinguish it from background and inform a timely response?

How can we identify a covert facility producing a chemical or biological agent?

UNCLASSIFIED © Crown 10 February 2016

How do we know if an individual has been exposed to a biological agent in a timely manner (before symptoms)? Can we modulate the immune system to improve the chances of survival: • after exposure to a biological

agent • before symptoms • before identification of the

agent?

How do we maintain high levels of protection for our armed forces but reduce the burden? Especially important when they need to do something

How do we know if something is contaminated and what’s the best way of dealing with that?

If a large stockpile of chemical weapons were needed to be dealt with, what’s the best, quickest and most expedient way of dealing with it?

How can we influence the international community by reinforcing what’s acceptable and what isn't, particularly where conventions don’t apply?

Back to the vision – can we make the use of CBW weapons obsolete because we don’t want to see this

UNCLASSIFIED

Exploitation

• CBR technical advice and reach-back – UK government, defence, Organisation for the Prohibition of

Chemical Weapons (OPCW)

• MOD capability – UK Armed Forces

• Cross-government science and technology capabilities • International partners and allies

10 February 2016

QUESTIONS?

10 February 2016

Guidance on submitting CDE research proposals

Competition Summary Innovation details

Finance and delivery schedule

Review and submit

Submission to competition: steps 1 > 5

CDE submission service

Review and submit

Step 1

Review and submit

Step 2

Review and submit

Step 3

The idea The benefit

The impact The approach The deliverables

Five factors

The idea

The benefit

The impact

The approach

The deliverables

Step 3

A. The Idea

B. Defence and security relevance

C. Your work plan and research approach

D. Exploitation beyond the proof-of concept stage

Step 3

Review and submit

Step 4

Review and submit

Step 5

Bidder dashboard

IN ASSESSMENT

SUBMITTED

NO FUND

Proposal status

Watermarking

CDE assessment

A. Operational relevance

B. Likelihood of exploitation

C. Builds critical S&T capability to meet UK needs

D. Scientific quality / innovation

E. Pushing the limits (S&T risk)

A. Impact on defence and security

B. Likelihood of exploitation

C. Advancing important science and technology

D. Innovation and scientific quality

E. Technical challenge

Impact on defence and security

Likelihood of exploitation

Advancing important S&T

Innovation and scientific quality

Technical challenge

And finally…..

Proposal health check

Effective proposals

Questions?

Centre for Defence Enterprise

cde@dstl.gov.uk www.gov.uk/dstl/cde

Questions

pm briefings from 9 feb 2016 innovation network event

Technology

selfyee event 14 feb 2016

education event - nimbin - rfs - feb 2021

aws 101 event london - feb 2014

techbrew - feb 23, 2017 | event program

saws rouche presentation hera event feb 2015

university briefings

superintendent’s newsletter...budget presentation event on...

professional briefings

post event release s valentine networking event, feb 12 by...

a light snow event: feb 2-4, 2003

introducing hyder british embassy event warsaw_18th feb...

svc learning event 7 feb 2013 s.gent

presentation splendid event agency(feb 25) 3

cips kenya-event-feb-2015 report

dec 12 2016 geneva 2020 feb event meeting

pip kwantlen uni-event feb 2011

east event guide feb 2011

briefings revista

linkedin: women in tech event 23 feb 2016

nscso staff business case briefings feb 2012 - barnet...